[go: up one dir, main page]

ITUB20160972A1 - Trattamento dell’alkaptonuria e della tirosinemia di tipo 1 - Google Patents

Trattamento dell’alkaptonuria e della tirosinemia di tipo 1

Info

Publication number
ITUB20160972A1
ITUB20160972A1 ITUB2016A000972A ITUB20160972A ITUB20160972A1 IT UB20160972 A1 ITUB20160972 A1 IT UB20160972A1 IT UB2016A000972 A ITUB2016A000972 A IT UB2016A000972A IT UB20160972 A ITUB20160972 A IT UB20160972A IT UB20160972 A1 ITUB20160972 A1 IT UB20160972A1
Authority
IT
Italy
Prior art keywords
alkaptonuria
tyrosinemia
treatment
type
Prior art date
Application number
ITUB2016A000972A
Other languages
English (en)
Inventor
Annalisa Santucci
Giulia Bernardini
Marcella Laschi
Fabrizio Manetti
Original Assignee
Univ Degli Studi Di Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Siena filed Critical Univ Degli Studi Di Siena
Priority to ITUB2016A000972A priority Critical patent/ITUB20160972A1/it
Priority to PCT/EP2017/054158 priority patent/WO2017144583A1/en
Priority to EP17706788.1A priority patent/EP3419609B1/en
Publication of ITUB20160972A1 publication Critical patent/ITUB20160972A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITUB2016A000972A 2016-02-23 2016-02-23 Trattamento dell’alkaptonuria e della tirosinemia di tipo 1 ITUB20160972A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITUB2016A000972A ITUB20160972A1 (it) 2016-02-23 2016-02-23 Trattamento dell’alkaptonuria e della tirosinemia di tipo 1
PCT/EP2017/054158 WO2017144583A1 (en) 2016-02-23 2017-02-23 Treatment of alkaptonuria and tyrosinemia type 1
EP17706788.1A EP3419609B1 (en) 2016-02-23 2017-02-23 Treatment of alkaptonuria and tyrosinemia type 1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2016A000972A ITUB20160972A1 (it) 2016-02-23 2016-02-23 Trattamento dell’alkaptonuria e della tirosinemia di tipo 1

Publications (1)

Publication Number Publication Date
ITUB20160972A1 true ITUB20160972A1 (it) 2017-08-23

Family

ID=56027041

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2016A000972A ITUB20160972A1 (it) 2016-02-23 2016-02-23 Trattamento dell’alkaptonuria e della tirosinemia di tipo 1

Country Status (3)

Country Link
EP (1) EP3419609B1 (it)
IT (1) ITUB20160972A1 (it)
WO (1) WO2017144583A1 (it)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012177214A1 (en) * 2011-06-23 2012-12-27 Swedish Orphan Biovitrum International Ab Liquid pharmaceutical composition comprising nitisinone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780127A (en) * 1982-03-25 1988-10-25 Stauffer Chemical Company Certain 2-(substituted benzoyl)-1,3-cyclohexanediones and their use as herbicides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012177214A1 (en) * 2011-06-23 2012-12-27 Swedish Orphan Biovitrum International Ab Liquid pharmaceutical composition comprising nitisinone

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHANIKA PHORNPHUTKUL ET AL: "Natural History of Alkaptonuria", NEW ENGLAND JOURNAL OF MEDICINE, vol. 347, no. 26, 26 December 2002 (2002-12-26), pages 2111 - 2121, XP055212052, ISSN: 0028-4793, DOI: 10.1056/NEJMoa021736 *
LASCHI MARCELLA ET AL: "Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.", CHEMMEDCHEM 5 APR 2016, vol. 11, no. 7, 5 April 2016 (2016-04-05), pages 674 - 678, XP002762816, ISSN: 1860-7187 *
SCHLUNE A ET AL: "Single dose NTBC-treatment of hereditary tyrosinemia type I", JOURNAL OF INHERITED METABOLIC DISEASE, KLUWER ACADEMIC PUBLISHERS, DO, vol. 35, no. 5, 4 February 2012 (2012-02-04), pages 831 - 836, XP035106005, ISSN: 1573-2665, DOI: 10.1007/S10545-012-9450-9 *
WENDY J INTRONE ET AL: "A 3-year randomized therapeutic trial of nitisinone in alkaptonuria", MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, AMSTERDAM, NL, vol. 103, no. 4, 28 April 2011 (2011-04-28), pages 307 - 314, XP028249729, ISSN: 1096-7192, [retrieved on 20110506], DOI: 10.1016/J.YMGME.2011.04.016 *
XU YU-LING ET AL: "Pyrazolone-quinazolone hybrids: A novel class of human 4-hydroxyphenylpyruvate dioxygenase inhibi", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 22, no. 19, 18 August 2014 (2014-08-18), pages 5194 - 5211, XP029061992, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2014.08.011 *

Also Published As

Publication number Publication date
WO2017144583A1 (en) 2017-08-31
EP3419609A1 (en) 2019-01-02
EP3419609B1 (en) 2023-04-26

Similar Documents

Publication Publication Date Title
IL272137A (en) Interleukin-21 muteins and methods of treatment
EP3732195A4 (en) CYTOTOXICITY-INDUCING THERAPEUTIC
HUE054548T2 (hu) Amino-triazolopiridin vegyületek és azok alkalmazása rák kezelésében
PL3426271T3 (pl) Sposoby leczenia guzów litych terapią skojarzoną
DK4272834T3 (da) Terapeutisk anvendelse af mitokondrier og kombinerede mitokondrielle midler
HUE064141T2 (hu) Azolopirimidin rákkal összefüggõ rendellenességek kezelésére
EP3487523A4 (en) THERAPEUTIC APPLICATIONS OF THE CPF1-BASED GENOME EDITION
IL254207B (en) Oral care compositions and methods of use
IL262211A (en) Gene therapy for treating mucopolysaccharidosis type ii
EP3554485C0 (en) Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices
IL270511A (en) Combination therapies using niraparib and pembrolizumab for treating cancer
IL263680A (en) Combination therapies
EP3619238A4 (en) CYTOTOXICITY INDUCING THERAPEUTIC
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
PL3503890T3 (pl) Stosowanie pridopidyny w leczeniu dystonii
IL262852A (en) Treatment of complement-mediated disorders
PT3458052T (pt) Tratamento combinado do cancro
IL250173B (en) Actuation mechanism and associated methods
IL281927A (en) Combination therapy for melanoma
EP3436467A4 (en) INNOVATIVE COMPOSITIONS AND THERAPEUTIC PROCEDURES
LT3463351T (lt) Parkinsono ligos gydymas
IL270900A (en) Treatment of cutaneous disorders
MA47111A (fr) Agents ciblant sirpgamma destinés à être utilisés dans le traitement du cancer
IT201700028184A1 (it) Composti e composizioni per il trattamento della fibrosi cistica
PL3727423T3 (pl) Leczenie zaburzeń metabolicznych z użyciem wariantów fgf21